Update: FTC Ban of Noncompetes Blocked

Published in Government Relations on August 22, 2024

Noncompete blog

Earlier this year, the FTC published a final rule that sought to ban most types of noncompete agreements used by businesses in several industries, including our healthcare industry. The proposed ban would not have prohibited noncompete agreements related to the sale of a business. It would, however, have banned most noncompete agreements between businesses and most staff, which are very commonplace in the DMEPOS industry, especially for skilled or licensed/credentialed staff (ATPs, RTs, RNs, CPEDs, etc.). 

Their final rule was published in April, and the ban on noncompete agreements was scheduled to go into effect in September of 2024. VGM published a summary of the final rule in May. As we mentioned in our summary of the final rule, the noncompete ban was met immediately with legal challenges from entities and industries alike. On Tuesday, August 20, Judge Ada Brown, a federal judge from the U.S. District Court in Texas, ruled that the FTC overstepped their statutory authority in the final rule and said that the ban was “arbitrary and capricious,” unreasonably overbroad, and lacked a reasonable explanation.” Judge Brown also cited that the ban in its proposed form would cause irreparable harm. 

The ruling this week means that the ban on noncompete agreements cannot and will not go into effect in September. The FTC has not yet said whether they will appeal the decision, but Victoria Graham, a spokesperson for the FTC, said they are considering that option. The FTC could also choose to address noncompete agreements in a different manner, perhaps through enforcement actions. 

If this is appealed further and based on some conflicting rulings in other states regarding noncompete agreements, it is possible this issue could make it to the Supreme Court. For the time being, companies are still at liberty to utilize noncompete agreements in their day-to-day business dealings with their employees. VGM will continue to monitor this topic and will issue further communications regarding any changes in the enforceability, timeline, or anything else related to this ban of noncompete agreements.

If you have questions or need additional information, please reach out to craig.douglas@vgm.com or alan.morris@vgm.com.


TAGS

  1. dmepos
  2. legislation
  3. vgm government

From Our Experts

Beyond the Shutdown and The Proposed Rule: Key Legislative Updates for the HME Industry thumbnail Beyond the Shutdown and The Proposed Rule: Key Legislative Updates for the HME Industry While the government shutdown and uncertainty surrounding CMS's Proposed Rule have dominated headlines, several important bills impacting HME providers continue to advance. Here's a quick look at three focused legislative priorities: Advocacy in Action: Texas DME Providers Stand Up For Patient Care thumbnail Advocacy in Action: Texas DME Providers Stand Up For Patient Care Texas DME providers are speaking out against proposed Medicaid reimbursement rate cuts that threaten access to essential medical equipment for vulnerable patients. At a recent public hearing, voices from across the state shared powerful stories about the real-world impact of these cuts—some as high as 85%. The Shutdown Has Ended—Now It's Time To Take Action thumbnail The Shutdown Has Ended—Now It's Time To Take Action The recent government shutdown created uncertainty across the healthcare landscape, and the DMEPOS community was no exception. In the weeks ahead, critical decisions will shape the future of our industry. By getting involved early—through advocacy, education, and collaboration—you can help ensure these policies support patients and providers rather than hinder them. Notably, the Continuing Resolution (CR) includes an extension of Medicare telehealth flexibilities through January 2026... New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform thumbnail New Issue Brief: Why Medicare's Competitive Bidding Program Needs Urgent Reform The Medicare competitive bidding program for durable medical equipment (DME) was designed to reduce costs—but it's failing patients and providers. A new issue brief from Pacific Research Institute and economist Wayne Winegarden highlights what changes are urgently needed. Champions of Change: DME Advocates Driving Real Change thumbnail Champions of Change: DME Advocates Driving Real Change Real change starts with real people. In this edition of Champions of Change, we're spotlighting two DME advocates who aren't just talking about problems—they're taking action. David Griffin and Gary Rench are showing us what it means to stand up for patients, providers, and the future of our industry. Join HME Industry Letter on CB Program to CMS Administrator Oz thumbnail Join HME Industry Letter on CB Program to CMS Administrator Oz HME suppliers, manufacturers, and distributors are invited to add their company's name to a letter to CMS Administrator Dr. Mehmet Oz regarding the Administration's DMEPOS/Home Health Proposed Rule that includes provisions for a new competitive bidding round. The letter specifically asks CMS to withdraw or delay the DMEPOS provisions in the Proposed Rule and re-engage with industry, patient, and clinical stakeholders to design an evidence-based, fraud-resistant, America-First framework. Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program thumbnail Take Action Today: Urge CMS to Pause and Re-Evaluate the Competitive Bidding Program Now is the time to raise our voices. With the formal announcement of the Competitive Bidding (CB) Program expected as early as the end of this month, we must act swiftly and decisively. Below are two key opportunities to engage with your U.S. Representative and encourage their support for a Congressional letter urging Centers for Medicare & Medicaid Services (CMS) to pause and reassess the CB Program. Legislative Momentum in the HME Industry: Key Updates & Action Items thumbnail Legislative Momentum in the HME Industry: Key Updates & Action Items The past few months have seen a surge of legislative activity in the home medical equipment sector, with several key developments shaping policy and advocacy efforts across the industry. From new bills introduced in Congress to formal comment submissions and stakeholder mobilization, these events reflect growing momentum around critical issues affecting providers and patients alike. This article offers a comprehensive recap of recent actions and outlines important next steps for those...